LINC02374

Across TCGA pan-cancer cohorts, LINC02374 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated LINC02374 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher LINC02374 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02374 expression acts as an unfavorable survival marker, although some lineages such as PAAD and LAML show a favorable association.

THCA, TGCT, and UCS are the cancer types where LINC02374 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	III,IV	0.112	0.858	<.001	78	view →
TGCT	DFS	Tertile	II,III,IV	0.339	0.955	<.001	72	view →
UCS	OS	Tertile	All	0.200	0.696	.001	54	view →
BLCA	DFS	Tertile	III,IV	0.155	0.481	<.001	54	view →
CESC	OS	Tertile	III,IV	0.095	0.755	<.001	54	view →
LIHC	DFS	Tertile	All	0.168	0.558	.005	48	view →
LUSC	OS	Tertile	All	0.278	0.743	<.001	39	view →
PAAD	DFS	Tertile	All	1.000	0.435	.012	36	view →
THYM	DFS	Tertile	All	0.091	0.872	<.001	36	view →
LAML	DFS	Tertile	All	0.832	0.490	.005	36	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
SKCM	OS	Tertile	IV	0.179	0.755	<.001	24	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

LINC02374–THCA (OS)

Open the THCA breakdown →